Colby College

DGAP-News: Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer

Thursday, October 14, 2021 - 12:08pm

NEW YORK, October 14, 2021 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced the appointment of Patrick Walsh as Chief Business Officer, effective today.

Key Points: 
  • NEW YORK, October 14, 2021 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced the appointment of Patrick Walsh as Chief Business Officer, effective today.
  • "Patrick is a seasoned business development executive who has spent his career helping to successfully build a number of public biopharmaceutical companies.
  • He brings to Immunic extensive leadership in building companies through strategic partnerships and non-dilutive funding," stated Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic.
  • Mr. Walsh was previously in Corporate Development at AVEO Oncology, during which time he worked on all aspects of business development.

Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer

Thursday, October 14, 2021 - 11:30am

In this newly created role, Mr. Walsh will be responsible for business development, including strategic partnering opportunities, and will become part of the executive management team of Immunic.

Key Points: 
  • In this newly created role, Mr. Walsh will be responsible for business development, including strategic partnering opportunities, and will become part of the executive management team of Immunic.
  • "Patrick is a seasoned business development executive who has spent his career helping to successfully build a number of public biopharmaceutical companies.
  • He brings to Immunic extensive leadership in building companies through strategic partnerships and non-dilutive funding," stated Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic.
  • Mr. Walsh was previously in Corporate Development at AVEO Oncology, during which time he worked on all aspects of business development.

Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer

Tuesday, September 21, 2021 - 11:30am

Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced the appointment of Chris Benecchi as Chief Commercial Officer.

Key Points: 
  • Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced the appointment of Chris Benecchi as Chief Commercial Officer.
  • In his new role, Mr. Benecchi will lead Sages global commercial efforts across all Sage programs, new product planning, strategy, and competitive intelligence.
  • View the full release here: https://www.businesswire.com/news/home/20210921005386/en/
    Chris Benecchi is an innovator, a transformative global commercial leader and a strategic launch expert, said Barry Greene, Chief Executive Officer at Sage Therapeutics.
  • Chris Benecchi joins Sage from Alexion, where he served as Vice President, Global Head of Commercial Excellence.

Guggenheim Securities Expands Technology Investment Banking Practice With the Addition of Tyler Dewing in Boston

Wednesday, September 15, 2021 - 3:30pm

NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that it has expanded its Technology Investment Banking Practice with the addition of Tyler Dewing in Boston.

Key Points: 
  • NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that it has expanded its Technology Investment Banking Practice with the addition of Tyler Dewing in Boston.
  • Mr. Dewing joins Guggenheim after 15 years at Harris Williams, where he was an early member of the firms Technology Investment Banking Group and most recently served as a Managing Director in Boston.
  • We are excited to welcome a banker of Tylers caliber to our Technology Investment Banking group, said Mark Van Lith, CEO of Guggenheim Securities and Head of Investment Banking.
  • Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm.

FORM Announces Jeff Wong as Chief Customer Officer

Wednesday, September 1, 2021 - 2:00pm

BRAINTREE, Mass., Sept. 1, 2021 /PRNewswire/ -- FORM , the leading field execution platform for teams, today announced the promotion of Jeff Wong to Chief Customer Officer.Wong will lead a global team responsible for service delivery, customer success, and support.

Key Points: 
  • BRAINTREE, Mass., Sept. 1, 2021 /PRNewswire/ -- FORM , the leading field execution platform for teams, today announced the promotion of Jeff Wong to Chief Customer Officer.Wong will lead a global team responsible for service delivery, customer success, and support.
  • "To deliver solutions that create value for our customers, we pair our powerful technology with a team that's dedicated to their success," shares Wong.
  • "At FORM, our team takes personal ownership for ensuring our customers have an optimal product experience, and are achieving their goals."
  • I'm thrilled for Jeff to serve as our Chief Customer Officer because his passion for delivering customer value is a key differentiator for us," says Moosani.

Petco Health and Wellness Company, Inc. Appoints Brian LaRose as Chief Financial Officer

Thursday, August 19, 2021 - 12:24pm

SAN DIEGO, Aug. 19, 2021 /PRNewswire/ --Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, today announced Brian LaRose has been appointed as Chief Financial Officer of the company, effective Aug. 19, 2021.

Key Points: 
  • SAN DIEGO, Aug. 19, 2021 /PRNewswire/ --Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, today announced Brian LaRose has been appointed as Chief Financial Officer of the company, effective Aug. 19, 2021.
  • LaRose will succeed Mike Nuzzo , who will continue in his role as Chief Operating Officer and President, Petco Services.
  • "Brian is a seasoned leader and I'm thrilled he's taking on this role," said Ron Coughlin , Petco Chairman and CEO.
  • About Petco, The Health + Wellness Co.
    Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners.

Omnicom Names Gregory Lundberg Senior Vice President of Investor Relations

Thursday, August 12, 2021 - 1:00pm

NEW YORK, Aug. 12, 2021 /PRNewswire/ --Omnicom Group Inc. (NYSE:OMC) today announcedGregory Lundberg will join the group as Senior Vice President of Investor Relations.

Key Points: 
  • NEW YORK, Aug. 12, 2021 /PRNewswire/ --Omnicom Group Inc. (NYSE:OMC) today announcedGregory Lundberg will join the group as Senior Vice President of Investor Relations.
  • In this role, Lundberg will be responsible for managing all Omnicom investor relations activities with the financial and investment communities.
  • Lundberg joins Omnicom from Outfront Media Inc. (formerly part of ViacomCBS) where he served as Senior Vice President of Investor Relations, ESG, and Financial Planning & Analysis.
  • Prior to Outfront Media, Lundberg held Investor Relations titles at iHeart Media, Clear Channel Outdoor and Frontier Communications.

BioTheryX Announces Appointments of Three New Members to its Board of Directors

Friday, August 6, 2021 - 2:00pm

"Nancy is a veteran life sciences executive and board member with significant expertise in corporate and commercial strategy.

Key Points: 
  • "Nancy is a veteran life sciences executive and board member with significant expertise in corporate and commercial strategy.
  • We look forward to Nancy, John, and Diantha's guidance as we aim to build a leading protein degradation company."
  • Nancy Miller-Rich has 35 years of experience in the healthcare industry, with significant expertise in business development and commercial strategy.
  • John A. Hohneker, M.D.brings over 30 years of drug development and leadership experience within the biotech and pharmaceutical industry to the BioTheryX board.

Colby Becomes First Liberal Arts College to Establish Major Academic Program in Artificial Intelligence

Friday, February 5, 2021 - 5:30pm

Colby College today announced that it has received a $30-million gift to establish the first cross-disciplinary institute for artificial intelligence (AI) at a liberal arts college.

Key Points: 
  • Colby College today announced that it has received a $30-million gift to establish the first cross-disciplinary institute for artificial intelligence (AI) at a liberal arts college.
  • Becoming a prominent center for the teaching and research of artificial intelligence and machine learning allows Colbys faculty and students to reimagine a liberal arts education for this century and beyond.
  • These Colby graduates will be deeply educated in the liberal arts with the powers of discernment to shape AI for the greater good.
  • Serving only undergraduates, Colby offers a rigorous academic program rooted in deep exploration of ideas and close interaction with world-class faculty scholars.

Colby College Poll Shows Statistical Dead Heat in Maine’s U.S. Senate Race

Tuesday, February 18, 2020 - 10:30pm

The poll was developed and sponsored by Colby College and conducted through the national pollster SocialSphere.

Key Points: 
  • The poll was developed and sponsored by Colby College and conducted through the national pollster SocialSphere.
  • However, the results indicate this could be the kind of race Sen. Collins has not had to deal with before.
  • According to the Colby poll, 79 percent of respondents paid attention to the impeachment proceeding.
  • Serving only undergraduates, Colby offers a rigorous academic program rooted in deep exploration of ideas and close interaction with world-class faculty scholars.